P
Pear Therapeutics Inc
NASDAQ:PEAR
Pear Therapeutics Inc
NASDAQ:PEAR
Price:
0.0077 USD
-15.38%
Market Closed
Updated:
May 7, 2024
Pear Therapeutics Inc
Cash from Operating Activities
|
Pear Therapeutics Inc
Cash from Operating Activities Peer Comparison
Comparables:
VEEV
INSP
EVH
DOCS
GDRX
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
P
|
Pear Therapeutics Inc
NASDAQ:PEAR
|
Cash from Operating Activities
-$113.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Veeva Systems Inc
NYSE:VEEV
|
Cash from Operating Activities
$911.3m
|
CAGR 3-Years
18%
|
CAGR 5-Years
24%
|
CAGR 10-Years
36%
|
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Cash from Operating Activities
$24.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Evolent Health Inc
NYSE:EVH
|
Cash from Operating Activities
$142.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Doximity Inc
NYSE:DOCS
|
Cash from Operating Activities
$179.6m
|
CAGR 3-Years
90%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
Cash from Operating Activities
$138.3m
|
CAGR 3-Years
2%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
See Also
What is Pear Therapeutics Inc's Cash from Operating Activities?
Cash from Operating Activities
-113.9m
USD
-113.9m
USD
Based on the financial report for Dec 31, 2022, Pear Therapeutics Inc's Cash from Operating Activities amounts to -113.9m USD.
What is Pear Therapeutics Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 1Y
-4%
-4%
Over the last year, the Cash from Operating Activities growth was -4%.
You don't have any saved screeners yet
